Patent Assignment
Reel/Frame 029150/0654
Change of Name
Recorded: 2012-10-18
Pages: 4
Assignor
PRO-PHARMACEUTICALS, INC.
Executed: 2011-05-26
Assignee
GALECTIN THERAPEUTICS INC.
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GEORGIA, 30071
Covered Properties
(11)
Modified Pectin
Patent:
7,491,708 →
Application:
08/024,487 →
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Patent:
6,645,946 →
Application:
09/818,596 →
Methods and Compositions for Reducing Side Effects in Chemotherapeutic Treatments
Co-Administration of a Polysaccharide with a Chemotherapeutic Agent for the Treatment of Cancer
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Delivery of a Therapeutic Agent in a Formulation for Reduced Toxicity
Galactose-Pronged Polysaccharides in a Formulation for Antifibrotic Therapies
Selectively Depolymerized Galactomannan Polysaccharide
Selectively Depolymerized Galactomannan Polysaccharide
Application:
12/962,296 →
Publication:
US 2011/0077217
Galactose-Pronged Polysaccharides in a Formulation for Antifibrotic Therapies
Galactose-Pronged Polysaccharides in a Formulation for Antifibrotic Therapies
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 31, 2001
From: KLYOSOV, ANATOLE; PLATT, DAVID
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 012420/0451 →
Assignment of Assignor's Interest
Mar 1, 2007
From: KLYOSOV, ANATOLE, DR.; PLATT, DAVID, DR.
To: PRO-PHARMACEUTICALS, INC
Reel/Frame 018942/0817 →
Assignment of Assignor's Interest
Mar 1, 2007
From: KLYOSOV, ANATOLE, DR.; PLATT, DAVID, DR.
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 018942/0833 →
Court Appointment of Trustee
Jun 4, 2007
From: GLYCOGENESYS, INC.
To: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
Reel/Frame 019365/0501 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019365/0568 →
Change of Name
Jun 4, 2007
From: SAFESCIENCE, INC.
To: GLYCOGENESYS, INC.
Reel/Frame 019365/0596 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: GLYCOGENESYS, INC.
Reel/Frame 019365/0599 →
Change of Name
Jun 4, 2007
From: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
To: PROSPECT PHARMACEUTICALS, INC.
Reel/Frame 019365/0633 →
Change of Name
Jun 4, 2007
From: PROSPECT PHARMACEUTICALS, INC.
To: PROSPECT THERAPEUTICS, INC.
Reel/Frame 019365/0638 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: GLYCOGENESYS, INC.
Reel/Frame 019375/0493 →
Assignment of Assignor's Interest
Jun 4, 2007
From: PLATT, DAVID
To: SAFESCIENCE, INC.
Reel/Frame 019390/0900 →
Assignment of Claims
Jun 4, 2007
From: MARK G. DEGIACOMO, CHAPTER 7 TRUSTEE OF GLYCOGENESYS, INC.
To: MARLBOROUGH RESEARCH AND DEVELOPMENT, INC.
Reel/Frame 019365/0510 →
Assignment of Assignor's Interest
May 14, 2008
From: PLATT,DAVID; KLYOSOV, ANATOLE; ZOMER, ELIEZER
To: PRO-PHARMACEUTICALS, INC
Reel/Frame 020975/0193 →
Security Agreement
Aug 26, 2009
From: PRO-PHARMACEUTICALS, INC.
To: 10X FUND, LP
Reel/Frame 023134/0968 →
Assignment of Assignor's Interest
Sep 4, 2009
From: PLATT, DAVID, DR.; ZOMER, ELIEZER, DR.; KLYOSOV, ANATOLE, DR.
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 023195/0598 →
Security Agreement
Feb 26, 2010
From: PRO-PHARMACEUTICALS, INC.
To: 10X FUND, LP
Reel/Frame 023995/0473 →
Assignment of Assignor's Interest
Nov 16, 2012
From: PLATT, DAVID; ZOMER, ELIEZER; KLYOSOV, ANATOLE
To: PRO-PHARMACEUTICALS, INC.
Reel/Frame 029315/0434 →
Assignment of Assignor's Interest
Sep 15, 2016
From: PLATT, DAVID
To: OXYGEN THERAPY, INC.
Reel/Frame 039756/0257 →
Release of Security Interest
Sep 17, 2019
From: 10X FUND L.P.
To: GALECTIN THERAPEUTICS, INC.
Reel/Frame 050399/0679 →